Dr. Reddy’s Shares Jump 5% Despite USFDA Observations at Bachupally
Summary :Dr. Reddy’s shares surged nearly 5% despite the USFDA issuing seven observations after inspecting its Bachupally biologics plant. Investors remained optimistic as most observations...
